|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Law and Finance显示文摘 | Rafael La Port Florencio Lopez-de-Silanes Andrei Shleifer and Robert Vishny | 1998 | Journal of Political Economy1998，106，6： | 1 |
| 2 | Corporate Ownership Around the Wurld 显示文摘 | La Port R Lopez - De - Silanes F Shleifer A | 1999 | the Journal of Finance1999，，54： | 1 |
| 3 | Prognos- tic value of galectin-3, a novel marker of fibrosis, in pa- tients with chronic heart failure:data from the DEAL-HF study显示文摘 | Lok DJ Van Der Meer P de la Porte PW | 2010 | Clin Res Cardiol2010，99，5： | 1 |
| 4 | Corporate Ownership Around the World显示文摘 | Rafael La Port Florencio Lopez-de-Silanes Andrei Shleifer and Robert Vishny | 1999 | Journal of Finance1999，，54： | 1 |
| 5 | Investor protection and corporate governance 显示文摘 | La Port R Lopez - De - Silanes F Shleifer A Vishny R | 2000 | Journal of Financial Economics2000，58，： | 1 |
| 6 | Investor Protection and Corporate Governance显示文摘 | Rafael La Port Florencio Lopez-de-Silanes An drei Shleifer and Robert Vishny | 2000 | Journal of Financial Economics2000，，58： | 1 |
| 7 | Investor protection and corporate valuation 显示文摘 | La Port R Lopez - De - Silanes F Shleifer A Vishny R | 2002 | Journal of Finance2002，57，3： | 1 |
| 8 | Investor Protection and Corporate Valuation显示文摘 | LA PORT R LOPEZ-DE-SILANES F SHLEIFER A | 2002 | Joumal of Finance2002，57，3： | 1 |
| 9 | Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure显示文摘 | Dirk J. Lok IJsbrand T. Klip Sjoukje I. Lok Pieta W. Bruggink-André de la Porte Erik Badings Jan van Wijngaarden Adriaan A. Voors Rudolf A. de Boer Dirk J. van Veldhuisen Peter van der Meer | 2013 | The American Journal of Cardiology2013，，： | 1 |
| 10 | The Regulation of Entry显示文摘 | DJANKOV S LA PORT R LOPES-DE-SILANES F SHLEIFER A | 2002 | The Quarterly Journal of Economics2002，117，1： | 1 |
| 11 | Epigenetic effects on the mouse mandible: Common features and discre- pancies in remodeling due to muscular dystrophy and re- sponse to food consistency显示文摘 | Renaud S Auffray JC de la Porte S | 2010 | BMC Evol Biol2010，10，： | 1 |
| 12 | Prognostic value of galectin - 3, a novel marker of fibrosis,in patients with chronic heart failure : Data from the DEAL - HF study 显示文摘 | Lok DJ van der Meer P de la Porte PW | 2010 | Clin Res Cardiol2010，99，5： | 1 |
| 13 | Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study显示文摘 | Lok D J Van Der Meer P de la Porte PW | 2010 | Clin Res Cardiol2010，99，： | 1 |
| 14 | Cyst fluid analysis in thedifferential diagnosis of pancreatic cystic lesions : a pooledanalysis显示文摘 | Van Der Waaij LA Porte RJ | 2005 | Gastrointest Endosc2005，62，3： | 1 |
| 15 | The relationship of physical activity to high density lipoprotein cholesterol in postmenopausal women 显示文摘 | Cauley JA La Porte PE Sandler RB | 1986 | J Chron Dis1986，39，9： | 1 |
| 16 | Corporate Ownership Around the World 显示文摘 | LA PORT R LOPEZ-DE-SILANES F SHLEIFER A | 1999 | Journal of Finance1999，54，2： | 1 |
| 17 | Investor Protection and Corporate Valuation 显示文摘 | LA PORT R LOPEZ-DE-SILANES F SHLEIFER A VISHNY R | 1999 | Journal of Fi- nance1999，57，3： | 1 |
| 18 | Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure : data from the DEAL-HF study显示文摘 | Lok DJ van der Meer P de la Porte PW | 2010 | Clin Res Cardiol2010，99，5： | 1 |
| 19 | Tunneling显示文摘 | JOHNSON SIMON LA PORT R LOPEZ-DE-SILANES F SHLEIFER A | 2000 | American Economic Review Papers and Proceedings2000，90，： | 1 |
| 20 | Prognostic value of galectin-3,a novel marker of fibrosis,in patients with chronic heart failure:data from the DEAL-HF study显示文摘 | Lok D J Van Der Meer P de la Porte PW | | 0，，05： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员